NFKB1 and liver cancer: In, 2013, it was reported that the addition of exogenous HMGB1 to H22 liver cancer cells, acting on RAGE and through the NF-kB pathway, increases the expression of matrix metalloproteinase 9 (MMP9), promoting the invasion of H22 cells (112).